Synthesis and multidrug resistance reversal activity of 1,2-disubstituted tetrahydroisoquinoline derivatives

Attila Mihályi1, Róbert Gáspár, Zita Zalán

  • 1Institute of Pharmaceutical Chemistry, University of Szeged, H-6701 Szeged, POB 121, Hungary.

Anticancer Research
|July 28, 2004
PubMed
Abstract

Insights

Researchers synthesized novel compounds to combat cancer multidrug resistance (MDR). One compound demonstrated significantly higher efficacy than verapamil in inhibiting P-glycoprotein (P-gp), offering a promising avenue for overcoming treatment failure.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Cancer Biology

Background:

  • Multidrug resistance (MDR) in cancer is a major obstacle to effective treatment.
  • Overexpression of P-glycoprotein (P-gp) is a primary mechanism driving MDR in tumor cells.

Purpose of the Study:

  • To synthesize and evaluate novel 1,2-disubstituted 1,2,3,4-tetrahydroisoquinoline derivatives as P-gp inhibitors.
  • To investigate the potential of these compounds to reverse multidrug resistance in cancer cells.

Main Methods:

  • Synthesis of structurally diverse 1,2-disubstituted 1,2,3,4-tetrahydroisoquinolines via N-substitution reactions.
  • Assay of P-gp inhibitory activity using rhodamine (6G) accumulation in MCF-7/Adr cells.
  • Evaluation of cytotoxicity on HeLa cells using an antiproliferative assay.

Main Results:

  • Five out of 24 synthesized compounds exhibited P-gp inhibition superior to the control, verapamil.
  • These active compounds showed significantly lower AC50 values compared to verapamil.
  • One specific compound demonstrated twice the efficacy of verapamil at ten times lower concentrations.

Conclusions:

  • Novel tetrahydroisoquinoline derivatives effectively inhibit P-gp and show multidrug resistance-reversal effects.
  • A lead compound exhibits significantly enhanced efficacy and potency compared to verapamil.
  • This molecule represents a promising candidate for further preclinical investigation and development in cancer therapy.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...